Among patients younger than 49 years, those with actinic keratosis had a nearly 7-times greater likelihood of developing cutaneous squamous cell carcinoma than patients without actinic keratosis.
A team of investigators sought to assess the impact of immunotherapy for malignant melanoma on testosterone levels, as well as to identify risk factors for low testosterone.
A team of investigators sought to assess the relationship between thiazides, thiazide-like diuretics, or calcium channel blockers and the development of basal cell carcinoma, squamous cell carcinoma, or cutaneous malignant melanoma.
A team of researchers assessed the relationship between BRAFV600-mutant ctDNA in plasma samples and outcomes in patients with BRAFV600 mutation-positive melanoma.
Investigators reviewed the clinical outcomes of patients with metastatic melanoma who electively discontinued PD-1 inhibitor therapy at 1 year.
